Currently out of the existing stock ratings of Joseph Stringer, 177 are a BUY (97.79%), 4 are a HOLD (2.21%).

Joseph Stringer

Work Performance Price Targets & Ratings Chart

Analyst Joseph Stringer, currently employed at NEEDHAM, carries an average stock price target met ratio of 28.98% that have a potential upside of 24.08% achieved within 109 days.

Joseph Stringer’s has documented 354 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PHAT, Phathom Pharmaceuticals at 12-Jul-2024.

Wall Street Analyst Joseph Stringer

Analyst best performing recommendations are on RNA (AVIDITY BIOSCIENCES ).
The best stock recommendation documented was for RNA (AVIDITY BIOSCIENCES ) at 6/10/2024. The price target of $35 was fulfilled within 2 days with a profit of $7.89 (29.1%) receiving and performance score of 145.52.

Average potential price target upside

APLS Apellis Pharmaceuticals INZY Inozyme Pharma  ACAD ACADIA Pharmaceuticals ALNY Alnylam Pharmaceuticals ANNX Annexon  ICPT Intercept Pharmaceuticals TBPH Theravance Biopharma ARNA Arena Pharmaceuticals RYTM Rhythm Pharmaceuticals VIR Vir Biotechnology STOK Stoke Therapeutics PHAT Phathom Pharmaceuticals CARA Cara Therapeutic IONS Ionis Pharmaceuticals PCVX Vaxcyte  PLRX Pliant Therapeutics  RNA Avidity Biosciences  CDTX Cidara Therapeutics ZEAL Zealand Pharma A/S ADR GILD Gilead Sciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

92

$52.47 (132.73%)

92

1 months 21 days ago

3/17 (17.65%)

$51.44 (126.82%)

108

Hold

48

$8.47 (21.43%)

62

1 months 26 days ago

7/8 (87.5%)

$8.32 (20.97%)

65

Buy

60

$20.47 (51.78%)

67

2 months 11 days ago

20/23 (86.96%)

$17.7 (41.84%)

216

Buy

85

$45.47 (115.03%)

85

2 months 11 days ago

10/14 (71.43%)

$42.7 (100.95%)

230

Buy

85

$45.47 (115.03%)

89

2 months 11 days ago

5/7 (71.43%)

$42.7 (100.95%)

391

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Joseph Stringer is most bullish on?

Potential upside of $45.47 has been obtained for APLS (APELLIS PHARMACEUTICALS)

Which stock is Joseph Stringer is most reserved on?

Potential downside of -$4.02 has been obtained for RYTM (RHYTHM PHARMACEUTICALS)

What Year was the first public recommendation made by Joseph Stringer?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?